Search filters

List of works by Frances K. Newman

A Live Human Parainfluenza Type 3 Virus Vaccine Is Attenuated and Immunogenic in Healthy Infants and Children ⬇️

scientific article published on December 1, 1995

A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants

scientific article published in May 2003

Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response

scientific article published on 25 January 2010

Analysis of Variola and Vaccinia Virus Neutralization Assays for Smallpox Vaccines ⬇️

scientific article published on May 16, 2012

Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax

scientific article

Antibody responses to vaccinia membrane proteins after smallpox vaccination

scientific article published on 4 June 2007

Antibody to native human immunodeficiency virus type 1 envelope glycoproteins induced by IIIB and MN recombinant gp120 vaccines. The NIAID AIDS Vaccine Evaluation Group.

scientific article

CD4+ T Cells Provide Intermolecular Help To Generate Robust Antibody Responses in Vaccinia Virus–Vaccinated Humans ⬇️

scientific article published on May 10, 2013

Characterization of a live, attenuated human parainfluenza type 3 virus candidate vaccine strain.

scientific article published on March 1995

Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challenge

scientific article published on 26 October 2007

Clinical responses to undiluted and diluted smallpox vaccine

scientific article published on 28 March 2002

Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults

scientific article

Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults

scientific article published on 9 December 2008

Detection of binding antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins following recombinant gp160 immunization measured by flow cytometry and enzyme immunoassays. The AIDS Vaccine Clinical Trials Networ

scientific article published on October 1992

Dose-dependent neutralizing-antibody responses to vaccinia

scientific article published on 23 January 2004

Dose-related effects of smallpox vaccine

scientific article published on 28 March 2002

Evaluation of a cold-adapted influenza B/Texas/84 reassortant virus (CRB-87) vaccine in young children ⬇️

scientific article published on September 1, 1992

Evaluation of a live attenuated, cold-adapted parainfluenza virus type 3 vaccine in children ⬇️

scientific article published on August 1, 1992

Evaluation of bovine, cold-adapted human, and wild-type human parainfluenza type 3 viruses in adult volunteers and in chimpanzees.

scientific article published on June 1991

Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children

scientific article published on 8 November 2004

Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza

scientific article published on 01 June 1996

Evaluation of smallpox vaccines using variola neutralization

scientific article

Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses

scientific article

Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functions

scientific article published on 8 September 2005

HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva. The NIAID AIDS Vaccine Clinical Trials Network

scientific article published on 01 February 1995

Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants

scientific article published in March 2005

Immune status in a primary smallpox vaccinee who failed to develop an immunization site reaction

scientific article published on 01 February 2005

Immunity to influenza in older adults with chronic obstructive pulmonary disease

scientific article published on 26 May 2004

Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine

scientific article published on 01 April 1992

Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine

scientific article

Increased anti-influenza A virus cytotoxic T cell activity following vaccination of the chronically ill elderly with live attenuated or inactivated influenza virus vaccine

scientific article

Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination

scientific article published on 30 August 2004

Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly

scientific article published in February 1996

Influenza Virus Vaccination of Patients With Chronic Lung Disease ⬇️

scientific article published on November 5, 1997

Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children

scientific article

Lymphocyte proliferative responses following immunization with human immunodeficiency virus recombinant GP160. The NIAID AIDS Vaccine Clinical Trials Network

scientific article published on January 1, 1992

Multidose, live attenuated, cold-recombinant, trivalent influenza vaccine in infants and young children

scientific article published on 01 May 1994

Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old.

scientific article published on 20 January 2004

Prevaccine Determination of the Expression of Costimulatory B7 Molecules in Activated Monocytes Predicts Influenza Vaccine Responses in Young and Older Adults

article

Recombinant gp160 vaccination schedule and MHC HLA type as factors influencing cellular responses to HIV-1 envelope glycoprotein. NIAID AIDS Vaccine Clinical Trials Network

scientific article published on 01 September 1995

Reducing the Dose of Smallpox Vaccine Reduces Vaccine‐Associated Morbidity without Reducing Vaccination Success Rates or Immune Responses

article

Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance

scientific article

Response to smallpox vaccine in persons immunized in the distant past

scientific article published on June 2003

Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario

scientific article published on 09 May 2013

Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors

scientific article published on 01 September 2001

Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children ⬇️

scientific article published on December 1, 2001

Serum antibody responses after intradermal vaccination against influenza

scientific article published on 03 November 2004

Stability of Undiluted and Diluted Vaccinia‐Virus Vaccine, Dryvax ⬇️

scientific article published on April 2, 2003

Temperature-sensitive phenotype of the human parainfluenza virus type 3 candidate vaccine strain (cp45) correlates with a defect in the L gene

scientific article published on January 1996

Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers

scientific article

Vaccine-induced antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins. NIAID AIDS Vaccine Clinical Trials Network

scientific article published in August 1994

Paulina is supported by:

About Paulina

Help